| Product Code: ETC7643871 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland mRNA Therapeutics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland mRNA Therapeutics Market - Industry Life Cycle |
3.4 Ireland mRNA Therapeutics Market - Porter's Five Forces |
3.5 Ireland mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Ireland mRNA Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Ireland, driving the demand for mRNA therapeutics. |
4.2.2 Growing investments in research and development in the biotechnology sector in Ireland. |
4.2.3 Favorable government initiatives and policies supporting the development and adoption of mRNA therapeutics in the country. |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA therapeutics development and production, limiting accessibility for patients. |
4.3.2 Regulatory challenges and uncertainties surrounding the approval process for mRNA therapeutics in Ireland. |
5 Ireland mRNA Therapeutics Market Trends |
6 Ireland mRNA Therapeutics Market, By Types |
6.1 Ireland mRNA Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F |
6.1.4 Ireland mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F |
6.2 Ireland mRNA Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Ireland mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Ireland mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F |
6.2.5 Ireland mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.2.6 Ireland mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland mRNA Therapeutics Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Ireland mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Ireland mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.4 Ireland mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland mRNA Therapeutics Market Import-Export Trade Statistics |
7.1 Ireland mRNA Therapeutics Market Export to Major Countries |
7.2 Ireland mRNA Therapeutics Market Imports from Major Countries |
8 Ireland mRNA Therapeutics Market Key Performance Indicators |
8.1 Percentage of research funding allocated to mRNA therapeutics development in Ireland. |
8.2 Number of clinical trials conducted for mRNA therapeutics in the country. |
8.3 Adoption rate of mRNA therapeutics by healthcare providers in Ireland. |
9 Ireland mRNA Therapeutics Market - Opportunity Assessment |
9.1 Ireland mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Ireland mRNA Therapeutics Market - Competitive Landscape |
10.1 Ireland mRNA Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Ireland mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here